CVS Health Co. (NYSE:CVS) Shares Acquired by Hohimer Wealth Management LLC

Hohimer Wealth Management LLC increased its stake in CVS Health Co. (NYSE:CVS) by 1.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 59,789 shares of the pharmacy operator’s stock after acquiring an additional 652 shares during the period. CVS Health makes up about 1.2% of Hohimer Wealth Management LLC’s holdings, making the stock its 18th largest holding. Hohimer Wealth Management LLC’s holdings in CVS Health were worth $4,721,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. SOA Wealth Advisors LLC. raised its stake in CVS Health by 4.9% in the fourth quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock valued at $226,000 after buying an additional 133 shares in the last quarter. Apella Capital LLC raised its stake in CVS Health by 4.2% in the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock valued at $272,000 after buying an additional 136 shares in the last quarter. Prairie Sky Financial Group LLC raised its stake in CVS Health by 4.1% in the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock valued at $285,000 after buying an additional 141 shares in the last quarter. WealthShield Partners LLC raised its stake in CVS Health by 3.2% in the fourth quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock valued at $355,000 after buying an additional 141 shares in the last quarter. Finally, Sugarloaf Wealth Management LLC raised its stake in CVS Health by 9.5% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock valued at $129,000 after buying an additional 142 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

CVS traded down $0.60 during trading on Thursday, reaching $56.84. The company’s stock had a trading volume of 10,997,914 shares, compared to its average volume of 11,937,702. The company’s fifty day moving average price is $67.98 and its 200-day moving average price is $72.13. CVS Health Co. has a 52-week low of $53.70 and a 52-week high of $83.25. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. The company has a market capitalization of $71.36 billion, a price-to-earnings ratio of 10.04, a price-to-earnings-growth ratio of 0.55 and a beta of 0.56.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The company had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. During the same quarter in the previous year, the business posted $2.20 earnings per share. CVS Health’s revenue was up 3.7% on a year-over-year basis. On average, equities analysts forecast that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.68%. CVS Health’s payout ratio is 46.75%.

Insider Activity

In related news, Director Edward J. Ludwig purchased 1,000 shares of CVS Health stock in a transaction dated Thursday, May 2nd. The stock was bought at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the transaction, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.24% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on CVS. Cantor Fitzgerald cut CVS Health from an “overweight” rating to a “neutral” rating and cut their price target for the company from $87.00 to $58.00 in a research note on Wednesday, May 1st. Royal Bank of Canada dropped their price objective on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. Wells Fargo & Company dropped their price objective on CVS Health from $76.00 to $60.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 7th. Truist Financial reaffirmed a “buy” rating and set a $66.00 price objective (down previously from $90.00) on shares of CVS Health in a report on Thursday, May 2nd. Finally, StockNews.com lowered CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Nine investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $76.75.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.